OCM
TECH icon

Oribel Capital Management’s Bio-Techne TECH Stock Holding History

Oribel Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-71,400
Closed -$5.03M – 90
2024
Q1 		$5.03M Sell
71,400
-45,400
-39% -$3.25M 0.29% 60
2023
Q4 		$9.01M Buy
+116,800
New +$7.69M 0.6% 57

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oribel Capital Management's TECH Position: Q2 2024 in Review

Oribel Capital Management sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 71,400 shares — an estimated $5.03M sold.

Oribel Capital Management first reported a position in TECH in Q4 2023 and held it in 2 quarters. The position peaked at $9.01M in Q4 2023. 571 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

  • Oribel Capital Management reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
  • Oribel Capital Management sold 71,400 Bio-Techne shares in Q2 2024, an estimated $5.03M.
  • Oribel Capital Management first reported a position in Bio-Techne in Q4 2023 and held it in 2 quarters.
  • Oribel Capital Management's Bio-Techne position peaked at $9.01M in Q4 2023.
  • 571 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Oribel Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.